Selected research
Industry Growth & Trends
Global Major Histocompatibility Complex Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Major Histocompatibility Complex market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Major Histocompatibility Complex market include Santa Cruz Biotechnology, ProImmune, Novus Biologicals, Miltenyi Biotec, Creative BioMart and Abbexa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Major Histocompatibility Complex market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Major Histocompatibility Complex market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Major Histocompatibility Complex market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Major Histocompatibility Complex.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Major Histocompatibility Complex market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Major Histocompatibility Complex Market by Company
Santa Cruz Biotechnology
ProImmune
Novus Biologicals
Miltenyi Biotec
Creative BioMart
Abbexa
Major Histocompatibility Complex Segment by Type
MHC Class II
MHC Class III
MHC Class I
Major Histocompatibility Complex Segment by Application
Medical Care
Research
Other
Major Histocompatibility Complex Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Histocompatibility Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Major Histocompatibility Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Histocompatibility Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Major Histocompatibility Complex companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- MHC Class II
- MHC Class III
- MHC Class I
Applications
- Medical Care
- Research
- Other
Companies covered
- Santa Cruz Biotechnology
- ProImmune
- Novus Biologicals
- Miltenyi Biotec
- Creative BioMart
- Abbexa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Major Histocompatibility Complex Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Major Histocompatibility Complex Market Size by Region (2021-2032)
- 1.4.1 Global Major Histocompatibility Complex Market Size by Region (2021-2026)
- 1.4.2 Global Major Histocompatibility Complex Market Size by Region (2027-2032)
- 1.5 Key Regions Major Histocompatibility Complex Market Size (2021-2032)
- 1.5.1 North America Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
- 1.5.4 South America Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
2 Major Histocompatibility Complex Market by Type
- 2.1 Type Introduction
- 2.1.1 MHC Class II
- 2.1.2 MHC Class III
- 2.1.3 MHC Class I
- 2.2 Global Major Histocompatibility Complex Market Size by Type
- 2.2.1 Global Major Histocompatibility Complex Market Size Overview by Type (2021-2032)
- 2.2.2 Global Major Histocompatibility Complex Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Major Histocompatibility Complex Market Size Forecasted by Type (2027-2032)
- 2.3 Global Major Histocompatibility Complex Market Size by Regions
- 2.3.1 North America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
3 Major Histocompatibility Complex Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Care
- 3.1.2 Research
- 3.1.3 Other
- 3.2 Global Major Histocompatibility Complex Market Size by Application
- 3.2.1 Global Major Histocompatibility Complex Market Size Overview by Application (2021-2032)
- 3.2.2 Global Major Histocompatibility Complex Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Major Histocompatibility Complex Market Size Forecasted by Application (2027-2032)
- 3.3 Global Major Histocompatibility Complex Market Size by Regions
- 3.3.1 North America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Major Histocompatibility Complex Industry Trends
- 4.2 Major Histocompatibility Complex Industry Drivers
- 4.3 Major Histocompatibility Complex Industry Opportunities and Challenges
- 4.4 Major Histocompatibility Complex Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Major Histocompatibility Complex Revenue (2021-2026)
- 5.2 Global Major Histocompatibility Complex Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Major Histocompatibility Complex Key Company Headquarters & Area Served
- 5.4 Global Major Histocompatibility Complex Company, Product Type & Application
- 5.5 Global Major Histocompatibility Complex Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Major Histocompatibility Complex Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025
- 5.6.3 2025 Major Histocompatibility Complex Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Santa Cruz Biotechnology
- 6.1.1 Santa Cruz Biotechnology Company Information
- 6.1.2 Santa Cruz Biotechnology Business Overview
- 6.1.3 Santa Cruz Biotechnology Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio
- 6.1.5 Santa Cruz Biotechnology Recent Developments
- 6.2 ProImmune
- 6.2.1 ProImmune Company Information
- 6.2.2 ProImmune Business Overview
- 6.2.3 ProImmune Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 ProImmune Major Histocompatibility Complex Product Portfolio
- 6.2.5 ProImmune Recent Developments
- 6.3 Novus Biologicals
- 6.3.1 Novus Biologicals Company Information
- 6.3.2 Novus Biologicals Business Overview
- 6.3.3 Novus Biologicals Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Novus Biologicals Major Histocompatibility Complex Product Portfolio
- 6.3.5 Novus Biologicals Recent Developments
- 6.4 Miltenyi Biotec
- 6.4.1 Miltenyi Biotec Company Information
- 6.4.2 Miltenyi Biotec Business Overview
- 6.4.3 Miltenyi Biotec Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Miltenyi Biotec Major Histocompatibility Complex Product Portfolio
- 6.4.5 Miltenyi Biotec Recent Developments
- 6.5 Creative BioMart
- 6.5.1 Creative BioMart Company Information
- 6.5.2 Creative BioMart Business Overview
- 6.5.3 Creative BioMart Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Creative BioMart Major Histocompatibility Complex Product Portfolio
- 6.5.5 Creative BioMart Recent Developments
- 6.6 Abbexa
- 6.6.1 Abbexa Company Information
- 6.6.2 Abbexa Business Overview
- 6.6.3 Abbexa Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Abbexa Major Histocompatibility Complex Product Portfolio
- 6.6.5 Abbexa Recent Developments
7 North America
- 7.1 North America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Major Histocompatibility Complex Market Size by Country (2021-2026)
- 7.3 North America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Major Histocompatibility Complex Market Size by Country (2021-2026)
- 8.3 Europe Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Major Histocompatibility Complex Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Major Histocompatibility Complex Market Size by Country (2021-2026)
- 10.3 South America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst